Equities

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

600436:SHH

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)200.04
  • Today's Change-45.44 / -18.51%
  • Shares traded1.03m
  • 1 Year change-22.47%
  • Beta1.5215
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments10,1738,6147,093
Total Receivables, Net1,1831,037875
Total Inventory3,3792,6282,438
Prepaid expenses341338193
Other current assets, total248835
Total current assets15,10012,70510,633
Property, plant & equipment, net826677613
Goodwill, net------
Intangibles, net291319221
Long term investments646697826
Note receivable - long term------
Other long term assets0.090.5016
Total assets17,08014,60412,521
LIABILITIES
Accounts payable506363322
Accrued expenses714401375
Notes payable/short-term debt1,1791,105893
Current portion long-term debt/capital leases342923
Other current liabilities, total451612524
Total current liabilities2,8832,5102,137
Total long term debt14310987
Total debt1,3561,2431,002
Deferred income tax306175
Minority interest544494432
Other liabilities, total10410085
Total liabilities3,7043,2742,816
SHAREHOLDERS EQUITY
Common stock603603603
Additional paid-in capital1,0951,0941,086
Retained earnings (accumulated deficit)11,6029,5597,816
Treasury stock - common------
Unrealized gain (loss)7573203
Other equity, total1.791.20(3)
Total equity13,37611,3309,705
Total liabilities & shareholders' equity17,08014,60412,521
Total common shares outstanding603603603
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.